Submitting Nonclinical Datasets for Evaluation of Rodent Carcinogenicity Studies of Pharmaceuticals
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 1, 2021
July 5, 2023
5558f50a-6637-45c7-9848-23f5e55738d6
Related Documents
Submitting Clinical Trial Datasets to Evaluate the Impact of Immunogenicity on the Pharmacokinetics of a Drug
Guidance DocumentJune 18, 2026Center for Drug Evaluation and Research
Submitting Clinical Trial Datasets and Documentation for Clinical Outcome Assessments Using Item Response Theory
Guidance DocumentNovember 6, 2023Center for Drug Evaluation and Research
Submitting Next Generation Sequencing Data to the Division of Antiviral Products Guidance for Industry Technical Specifications Document
Guidance DocumentJuly 18, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.